Join the Cannabidiol group to help and get support from people like you.
Cannabidiol News (Page 3)
Related terms: CBD
Vaping Cannabidiol Fairly Common Among Teens
MONDAY, Aug. 21, 2023 – Vaping cannabidiol (CBD) is common among U.S. teens, according to a study published online Aug. 16 in JAMA Network Open. Hongying Daisy Dai, Ph.D., from University of...
CBD Vapes Rising in Popularity Among Teens
THURSDAY, Aug. 17, 2023 – Vaping CBD (cannabidiol) is on the rise among middle and high school students, according to a national U.S. survey, and health experts warn there can be serious risks...
With Marijuana's Legalization, Cannabis Poisonings Are on the Rise
THURSDAY, July 27, 2023 – In recent years, the legalization of both medical and recreational marijuana has become the new normal across much of North America. The problem: New research finds that as...
FDA Medwatch Alert: FDA Issues Warning Letters to Companies Illegally Selling CBD and Delta-8 THC Products
May 04, 2022 – Today, the U.S. Food and Drug Administration issued warning letters to five companies for selling products labeled as containing delta-8 tetrahydrocannabinol (delta-8 THC) in ways...
FDA Approves Epidiolex (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
CARLSBAD, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) – GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines,...
FDA Medwatch Alert: FDA Warns Companies Illegally Selling CBD Products to Treat Medical Conditions, Opioid Addiction
April 23, 2020 – The U.S. Food and Drug Administration has issued warning letters to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the...
FDA Medwatch Alert: FDA, FTC Warn Company Marketing Unapproved Cannabidiol Products with Unsubstantiated Claims to Treat Teething and Ear Pain in Infants, Autism, ADHD, Parkinson’s and Alzheimer’s Disease
October 22, 2019 – Today, the U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter to Rooted Apothecary LLC, of Naples, Florida, for illegally selling...
FDA Approves Epidiolex (cannabidiol) to Treat Lennox-Gastaut Syndrome and Dravet Syndrome
June 25, 2018 – The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy,...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Anxiety, Lennox-Gastaut Syndrome